This inventor holds 3 USPTO granted patents. Top assignees: Sandoz Gmbh, Sandoz Ltd., (Sandoz Ag). Active years: 1976-1980.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1976-1980
Title: Heribert Wagner: Innovator in Anti-Obesity Treatments
Introduction
Heribert Wagner is a notable inventor based in Pfeffingen, Switzerland. He has made significant contributions to the field of pharmacology, particularly in the development of anti-obesity agents. With a total of 3 patents to his name, Wagner's work has the potential to impact the treatment of obesity significantly.
Latest Patents
Wagner's latest patents include innovative uses of alpha-blocking agents in the treatment of obesity. One of his key inventions focuses on the use of 9,10-dihydroergot-peptide alkaloids as anti-obesity agents. These compounds are designed to reduce free fatty acids in the blood and suppress appetite, providing a new approach to managing obesity.
Career Highlights
Throughout his career, Wagner has worked with prominent companies in the pharmaceutical industry, including Sandoz GmbH and Sandoz Ltd. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in medical treatments.
Collaborations
Wagner has collaborated with several professionals in his field, including Maria Milavec and Gunter Engel. These partnerships have facilitated the exchange of ideas and expertise, enhancing the quality of his research and inventions.
Conclusion
Heribert Wagner's contributions to the field of anti-obesity treatments through his innovative patents highlight his role as a significant inventor. His work continues to pave the way for new therapeutic options in the fight against obesity.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile